Phytase enzyme produced by Pseudomonas fluorescens strain BD50104 expressing an altered appA 6-phytase gene from Escherichia coli strain K12 in animal food: FDA records
What has FDA said about Phytase enzyme produced by Pseudomonas fluorescens strain BD50104 expressing an altered appA 6-phytase gene from Escherichia coli strain K12 in animal food?
FDA's animal food GRAS notices inventory lists 3 notices for Phytase enzyme produced by Pseudomonas fluorescens strain BD50104 expressing an altered appA 6-phytase gene from Escherichia coli strain K12. AGRN 39 (filed Jul 14, 2020; intended species: Poultry): FDA's response, as the inventory prints it: "At notifier’s request, FDA ceased to evaluate the notice" (letter dated Apr 2, 2021). AGRN 55 (filed Jan 20, 2022; intended species: Broiler chickens): FDA's response, as the inventory prints it: "FDA has no questions" (letter dated Sep 16, 2022). AGRN 61 (filed Feb 10, 2023; intended species: Swine): FDA's response, as the inventory prints it: "FDA has no questions" (letter dated Nov 2, 2023).
Each notice covers the use and the animals it describes; FDA's response to one notice does not carry over to another use or species.
AAFCO ingredient definitions, published by the Association of American Feed Control Officials (a membership association, not a federal agency), are a separate list and are not covered here. A substance missing from these FDA records may still appear in that list or elsewhere.
GRAS notices
FDA's letters, in FDA's words
“Based on the information contained in the notice and the amendments, submitted on behalf of BASF Enzymes LLC, as well as other information available to FDA, we have no questions at this time regarding the notifier’s conclusion that phytase from a Pseudomonas fluorescens strain expressing an altered appA 6-phytase gene from Escherichia coli strain K12 to be used to increase the availability of phytin-bound phosphorus in broiler diets at a recommended supplementation level of a minimum of 500 U/kg to a maximum of 2000 U/kg in complete feed is GRAS.”
FDA, response letter on AGRN 55, dated Sep 16, 2022.
“Based on the information contained in the notice and amendment, submitted on behalf of BASF Enzymes LLC, and other information available to FDA, we have no questions at this time regarding the notifier’s conclusion that phytase from a Pseudomonas fluorescens strain expressing an altered appA 6-phytase gene from Escherichia coli strain K12 to be used to increase the availability of phytin-bound phosphorus in swine diets at a recommended supplementation level of a minimum of 500 U/kg to a maximum of 2000 U/kg in complete feed is GRAS.”
FDA, response letter on AGRN 61, dated Nov 2, 2023.
Sentences are copied from the text of FDA's PDF letters. A sentence is left out when the PDF text could not be copied exactly (for example a number printed with an exponent).
Sources
- FDA: Current Animal Food GRAS Notices Inventory
- FDA: Generally Recognized as Safe (GRAS) Notification Program (animal food)
- eCFR: Title 21, Parts 573, 582, 584 and 589 (section headings via the eCFR API)
Records last pulled Nov 15, 2026. Every entry links to the original public record.
These are FDA records shown as FDA published them: notices, FDA's response wording and regulation headings. A record is not a finding by this site, and an FDA response to a GRAS notice covers the use and the animals the notice describes. AAFCO ingredient definitions, published by the Association of American Feed Control Officials (a membership association, not a federal agency), are a separate list and are not covered here. A substance missing from these FDA records may still appear in that list or elsewhere. Report an error or add a company response.